A Porgador
Overview
Explore the profile of A Porgador including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kolusheva S, Yossef R, Kugel A, Katz M, Volinsky R, Welt M, et al.
Anal Chem
. 2012 Jul;
84(14):5925-31.
PMID: 22746165
We demonstrate a novel array-based diagnostic platform comprising lipid/polydiacetylene (PDA) vesicles embedded within a transparent silica-gel matrix. The diagnostic scheme is based upon the unique chromatic properties of PDA, which...
2.
Rosental B, Appel M, Yossef R, Hadad U, Brusilovsky M, Porgador A
Curr Med Chem
. 2012 Mar;
19(12):1780-91.
PMID: 22414084
In recent years, the effects of cancer chemotherapy and radiotherapy (CT/RT) regimens as they apply to the immune system have been explored. NK cells represent the main cytotoxic arm of...
3.
Daniely D, Portnoi M, Shagan M, Porgador A, Givon-Lavi N, Ling E, et al.
Clin Exp Immunol
. 2006 Apr;
144(2):254-63.
PMID: 16634799
For most bacteria, adherence to human cells is achieved by bacterial lectins binding to mammalian surface glyconjugates. 6-Phosphogluconate dehydrogenase (6PGD) was identified by us as one of Streptococcus pneumoniae cell...
4.
Mandelboim O, Porgador A
Int J Biochem Cell Biol
. 2001 Oct;
33(12):1147-50.
PMID: 11606250
Combating diseases such as cancer and virus infection is one of the major goals of the next millennium. Remarkably, our immune system has developed a unique cell type called Natural...
5.
Arnon T, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O
Eur J Immunol
. 2001 Sep;
31(9):2680-9.
PMID: 11536166
Natural killer (NK) cells destroy virus-infected and tumor cells without prior antigen stimulation. The NK cell cytotoxicity is regulated in large part by the expression of NK cell receptors that...
6.
Mandelboim O, Lieberman N, Lev M, Paul L, Arnon T, Bushkin Y, et al.
Nature
. 2001 Mar;
409(6823):1055-60.
PMID: 11234016
Natural killer (NK) cells destroy virus-infected and tumour cells, apparently without the need for previous antigen stimulation. In part, target cells are recognized by their diminished expression of major histocompatibility...
7.
8.
Wherry E, Puorro K, Porgador A, Eisenlohr L
J Immunol
. 1999 Sep;
163(7):3735-45.
PMID: 10490969
The role of epitope expression levels in CD8+ T cell priming has been controversial. Yet this parameter is of great importance in the design of rational approaches to optimize CTL...
9.
Song R, Porgador A, Harding C
Immunology
. 1999 Aug;
97(2):316-24.
PMID: 10447748
These studies addressed the nature and origin of peptide-receptive class I major histocompatibility complex (MHC-I) molecules used to present exogenous antigens. Peptide-receptive Kb molecules in transporter for antigen presentation (TAP)1-/-...
10.
Porgador A, Staats H, Itoh Y, Kelsall B
Infect Immun
. 1998 Nov;
66(12):5876-81.
PMID: 9826368
We previously reported that cholera toxin (CT) was required as a mucosal adjuvant for the induction of peptide-specific cytotoxic T lymphocytes (CTL) following intranasal immunization with CTL epitope peptides (A....